Thus, specific CLR expression profiles on DC subsets correlated with unique DCs’ features in melanoma patients, suggesting that melanoma tumor may shape DCs’ features by exploiting the plasticity of the CLR machinery. The gene discussed is DCLK3; the disease is neoplasm.